{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T04:44:53Z","timestamp":1775623493388,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T00:00:00Z","timestamp":1329350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11011-012-9280-3","type":"journal-article","created":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T02:13:06Z","timestamp":1329271986000},"page":"151-158","source":"Crossref","is-referenced-by-count":29,"title":["Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram"],"prefix":"10.1007","volume":"27","author":[{"given":"J. M.","family":"Warwick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. D.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Cassimjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lochner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hemmings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Moolman-Smook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Beetge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,16]]},"reference":[{"key":"9280_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrn1056","volume":"4","author":"R Adolphs","year":"2003","unstructured":"Adolphs R (2003) Cognitive neuroscience of human social behaviour. Nat Rev Neurosci 4:165\u2013178","journal-title":"Nat Rev Neurosci"},{"key":"9280_CR2","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC","edition":"4"},{"key":"9280_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.mp.4000261","volume":"2","author":"K Blum","year":"1997","unstructured":"Blum K, Braverman ER, Wu S et al (1997) Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid\/avoidant behaviours (SAB). Mol Psychiatry 2:239\u2013246","journal-title":"Mol Psychiatry"},{"key":"9280_CR4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00004714-199812000-00005","volume":"18","author":"N Bonhomme","year":"1998","unstructured":"Bonhomme N, Esposito E (1998) Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review. J Clin Psychopharmacol 18:447\u2013454","journal-title":"J Clin Psychopharmacol"},{"key":"9280_CR5","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.npp.1300683","volume":"30","author":"MM Win De","year":"2005","unstructured":"De Win MM, Habraken JB, Reneman L et al (2005) Validation of ((123)I)beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology 30:996\u20131005","journal-title":"Neuropsychopharmacology"},{"key":"9280_CR6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1523\/JNEUROSCI.15-01-00821.1995","volume":"15","author":"SL Dewey","year":"1995","unstructured":"Dewey SL, Smith GS, Logan J et al (1995) Serotonergic modulation of striatal dopamine measured with Positron Emission Tomography (PET) and in vivo microdialysis. J Neurosci 15:821\u2013829","journal-title":"J Neurosci"},{"key":"9280_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(08)00901-1","volume":"172","author":"E Esposito","year":"2008","unstructured":"Esposito E, Di Matteo V, Di Giovanni G (2008) Serotonin\u2013dopamine interaction: an overview. Prog Brain Res 172:3\u20136","journal-title":"Prog Brain Res"},{"key":"9280_CR8","volume-title":"Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV)","author":"MB First","year":"1996","unstructured":"First MB, Spitzer RL, Gibbon M et al (1996) Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV). American Psychiatric Press, Inc, Washington, DC"},{"key":"9280_CR9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/sj.tpj.6500026","volume":"1","author":"S Fuke","year":"2001","unstructured":"Fuke S, Suo S, Takahashi N et al (2001) The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1:152\u2013156","journal-title":"Pharmacogenomics J"},{"key":"9280_CR10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/(SICI)1098-2396(199805)29:1<80::AID-SYN7>3.0.CO;2-7","volume":"29","author":"KA Grant","year":"1998","unstructured":"Grant KA, Shively CA, Nader MA et al (1998) Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography. Synapse 29:80\u201383","journal-title":"Synapse"},{"key":"9280_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0893-133X(99)00099-8","volume":"22","author":"A Heinz","year":"2000","unstructured":"Heinz A, Goldman D, Jones DW et al (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22:133\u2013139","journal-title":"Neuropsychopharmacology"},{"key":"9280_CR12","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1176\/appi.ajp.157.10.1700","volume":"157","author":"LK Jacobsen","year":"2000","unstructured":"Jacobsen LK, Staley JK, Zoghbi SS et al (2000) Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 157:1700\u20131703","journal-title":"Am J Psychiatry"},{"key":"9280_CR13","first-page":"426","volume":"36","author":"MR Johnson","year":"1996","unstructured":"Johnson MR, Lydiard RB, Zealberg JJ et al (1994) Plasma and CSF HVA levels in panic patients with co-morbid social phobia. Biol Psychiatry 36:426\u2013427","journal-title":"Biol Psychiatry"},{"key":"9280_CR14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/ajp.153.4.466","volume":"153","author":"S Kapur","year":"1996","unstructured":"Kapur S, Remington G (1996) Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153:466\u2013476","journal-title":"Am J Psychiatry"},{"key":"9280_CR15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00041444-200112000-00006","volume":"11","author":"JL Kennedy","year":"2001","unstructured":"Kennedy JL, Neves-Perreira M, King N et al (2001) Dopamine system genes not linked to social phobia. Psych Genetics 11:213\u2013217","journal-title":"Psych Genetics"},{"key":"9280_CR16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O et al (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62:593\u2013602","journal-title":"Arch Gen Psychiatry"},{"key":"9280_CR17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000106474","volume":"55","author":"CH Kim","year":"2007","unstructured":"Kim CH, Cheon KA, Koo MS et al (2007) Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with (123I)IPT SPECT before and after treatment with serotonin reuptake inhibitors. Neuropsychobiology 55:156\u2013162","journal-title":"Neuropsychobiology"},{"key":"9280_CR18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0165-1781(86)90123-X","volume":"19","author":"R King","year":"1986","unstructured":"King R, Mefford IN, Wang C et al (1986) CSF dopamine levels correlate with extraversion in depressed patients. Psychiatry Res 19:305\u2013310","journal-title":"Psychiatry Res"},{"key":"9280_CR19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.npp.1300036","volume":"28","author":"A Kugaya","year":"2003","unstructured":"Kugaya A, Seneca NM, Snyder SJ et al (2003) Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 28:413\u2013420","journal-title":"Neuropsychopharmacology"},{"key":"9280_CR20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/appi.ajp.157.2.290","volume":"157","author":"A Laakso","year":"2000","unstructured":"Laakso A, Vilkman H, Kajander J et al (2000) Prediction of detached personality in healthy subjects by low dopamine transporter binding. Am J Psychiatry 157:290\u2013292","journal-title":"Am J Psychiatry"},{"key":"9280_CR21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/da.20014","volume":"19","author":"M Lader","year":"2004","unstructured":"Lader M, Stender K, Burger V et al (2004) Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study. Depress Anxiety 19:241\u2013248","journal-title":"Depress Anxiety"},{"key":"9280_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000414022","volume":"22","author":"MR Liebowitz","year":"1987","unstructured":"Liebowitz MR (1987) Social phobia. Mod Probl Pharmacopsychiat 22:141\u2013173","journal-title":"Mod Probl Pharmacopsychiat"},{"key":"9280_CR23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archpsyc.49.4.290","volume":"49","author":"MR Liebowitz","year":"1992","unstructured":"Liebowitz MR, Schneier FR, Campeas R et al (1992) Phenelzine vs atenolol in social phobia: a placebo-controlled trial. Arch Gen Psychiatry 49:290\u2013300","journal-title":"Arch Gen Psychiatry"},{"key":"9280_CR24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0893-133X(00)00216-5","volume":"24","author":"D Martinez","year":"2001","unstructured":"Martinez D, Gerlernter J, Abi-Dargham A et al (2001) The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24:553\u2013560","journal-title":"Neuropsychopharmacology"},{"key":"9280_CR25","first-page":"216A","volume":"31S","author":"M Mayleben","year":"1992","unstructured":"Mayleben M, Gariepy J, Tancer M et al (1992) Genetic differences in social behaviour: neurobiological mechanisms in a mouse model (abstract). Biol Psychiatry 31S:216A","journal-title":"Biol Psychiatry"},{"key":"9280_CR26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ajmg.b.10948","volume":"114","author":"J Mill","year":"2002","unstructured":"Mill J, Asherson P, Browes C et al (2002) Expression of the dopamine transporter gene is regulated by the 3\u2032 UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am Med Genet 114:975\u2013979","journal-title":"Am Med Genet"},{"key":"9280_CR27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4088\/JCP.v60n1203","volume":"60","author":"S Pallanti","year":"1999","unstructured":"Pallanti S, Quercioli L, Rossi A et al (1999) The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation. J Clin Psychiatry 60:819\u2013823","journal-title":"J Clin Psychiatry"},{"key":"9280_CR28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF01276462","volume":"100","author":"W Pirker","year":"1995","unstructured":"Pirker W, Asenbaum S, Kasper S et al (1995) Beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J Neural Transm Gen Sect 100:247\u2013256","journal-title":"J Neural Transm Gen Sect"},{"key":"9280_CR29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/jnp.8.4.383","volume":"8","author":"IH Richard","year":"1996","unstructured":"Richard IH, Schiffer RB, Kurlan R (1996) Anxiety and Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 8:383\u2013392","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9280_CR30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1155\/2000\/421719","volume":"12","author":"C Rorden","year":"2000","unstructured":"Rorden C, Brett M (2000) Stereotaxic display of brain lesions. Behav Neurol 12:191\u2013200","journal-title":"Behav Neurol"},{"key":"9280_CR31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1021427314941","volume":"28","author":"DC Rowe","year":"1998","unstructured":"Rowe DC, Stever C, Gard JM et al (1998) The relation of the dopamine transporter gene (DAT1) to symptoms of internalising disorders in children. Behav Genet 28:215\u2013225","journal-title":"Behav Genet"},{"key":"9280_CR32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0033291707001699","volume":"38","author":"AM Ruscio","year":"2008","unstructured":"Ruscio AM, Brown TA, Chiu WT et al (2008) Social fears and social phobia in the USA: results from the national comorbidity survey replication. Psychol Med 38:15\u201328","journal-title":"Psychol Med"},{"key":"9280_CR33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/appi.ajp.157.3.457","volume":"157","author":"FR Schneier","year":"2000","unstructured":"Schneier FR, Liebowitz MR, Abi-Dargham A et al (2000) Low dopamine D2 receptor binding potential in social phobia. Am J Psychiatry 157:457\u2013459","journal-title":"Am J Psychiatry"},{"key":"9280_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/da.20268","volume":"25","author":"FR Schneier","year":"2008","unstructured":"Schneier FR, Martinez D, Abi-Dargham A et al (2008) Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depress Anxiety 25:1\u20137","journal-title":"Depress Anxiety"},{"key":"9280_CR35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/da.20543","volume":"26","author":"FR Schneier","year":"2009","unstructured":"Schneier FR, Abi-Dargham A, Martinez D et al (2009) Dopamine transporters, D(2) receptors, and dopamine release in generalized social anxiety disorder. Depress Anxiety 26:411\u2013418","journal-title":"Depress Anxiety"},{"key":"9280_CR36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4088\/JCP.v66n0420b","volume":"66","author":"SI Schutters","year":"2005","unstructured":"Schutters SI, van Megan HJ, Westenberg HG (2005) Efficacy of Quetiapine in generalized social anxiety disorder: results from an open-label study. J Clin Psychiatry 66:540\u2013542","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 20","key":"9280_CR37","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH et al (1998) The MINI-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22\u201333","journal-title":"J Clin Psychiatry"},{"key":"9280_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/syn.20574","volume":"63","author":"GS Smith","year":"2009","unstructured":"Smith GS, Ma Y, Dhawan V et al (2009) Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with (11C)-raclopride and positron emission tomography. Synapse 63:1\u20136","journal-title":"Synapse"},{"key":"9280_CR39","first-page":"CD001206","volume":"4","author":"DJ Stein","year":"2004","unstructured":"Stein DJ, Ipser J, van Balkom A (2004) Pharmacotherapy for social phobia. Cochrane Database Syst Rev 4:CD001206","journal-title":"Cochrane Database Syst Rev"},{"key":"9280_CR40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1176\/ajp.154.12.1711","volume":"154","author":"J Tiihonen","year":"1997","unstructured":"Tiihonen J, Kuikka J, Bergstrom K et al (1997) Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 154:239\u2013242","journal-title":"Am J Psychiatry"},{"issue":"Suppl. 2","key":"9280_CR41","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/00004850-200008002-00004","volume":"15","author":"GJ Linden Van der","year":"2000","unstructured":"Van der Linden GJ, Stein DJ, Van Balkom AJ (2000) The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomised controlled trials. Int Clin Psychopharmacol 15(suppl 2):S15\u2013S23","journal-title":"Int Clin Psychopharmacol"},{"key":"9280_CR42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2967\/jnumed.107.045518","volume":"49","author":"NJ Wee Van der","year":"2008","unstructured":"Van der Wee NJ, Van Veen JF, Stevens H et al (2008) Increased serotonin and dopamine transporter binding in psychotropic medication-na\u00efve patients with generalised social anxiety disorder shown by 123I-\u03b2-(4-iodophenyl)-tropane SPECT. J Nucl Med 49:757\u2013763","journal-title":"J Nucl Med"},{"key":"9280_CR43","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0888-7543(05)80138-7","volume":"14","author":"DJ Vandenbergh","year":"1992","unstructured":"Vandenbergh DJ, Persico AM, Hawkins AL et al (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104\u20131106","journal-title":"Genomics"},{"key":"9280_CR44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2156-6-55","volume":"6","author":"SH VanNess","year":"2005","unstructured":"VanNess SH, Owens MJ, Kilts CD (2005) The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet 6:55","journal-title":"BMC Genet"},{"key":"9280_CR45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0959-4388(96)80024-9","volume":"6","author":"T Wichmann","year":"1996","unstructured":"Wichmann T, DeLong MR (1996) Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 6:751\u2013758","journal-title":"Curr Opin Neurobiol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-012-9280-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-012-9280-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-012-9280-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T18:27:57Z","timestamp":1561314477000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-012-9280-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,16]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9280"],"URL":"https:\/\/doi.org\/10.1007\/s11011-012-9280-3","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,16]]}}}